 | • レポートコード：D005-01012 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、甲状腺障害治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。甲状腺障害治療の種類別市場規模（甲状腺機能低下症、甲状腺機能亢進症）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：GlaxoSmithKline、Allergan Plc、Abbott Laboratories、Pfizer, Inc、Takeda Pharmaceutical、Novartis International AG、Lannett Company, Inc、Sanofi、AbbVie, Inc、Merck KGaA、Mylan N.V ・地域別グローバル市場分析 2015年-2020年 ・甲状腺障害治療の北米市場（アメリカ、カナダ、メキシコ） ・甲状腺障害治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・甲状腺障害治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・甲状腺障害治療の南米市場（ブラジル、アルゼンチン） ・甲状腺障害治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：甲状腺機能低下症、甲状腺機能亢進症 ・用途別分析：病院、クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Thyroid Gland Disorders Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.8% in the forecast period of 2020 to 2025 and will expected to reach USD 1969.2 million by 2025, from USD 1834.3 million in 2019.
The Thyroid Gland Disorders Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Thyroid Gland Disorders Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Thyroid Gland Disorders Treatment market has been segmented into:
Hypothyroidism
Hyperthyroidism
By Application, Thyroid Gland Disorders Treatment has been segmented into:
Hospitals
Clinics
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Thyroid Gland Disorders Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Thyroid Gland Disorders Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Thyroid Gland Disorders Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Thyroid Gland Disorders Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Thyroid Gland Disorders Treatment Market Share Analysis
Thyroid Gland Disorders Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Thyroid Gland Disorders Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Thyroid Gland Disorders Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Thyroid Gland Disorders Treatment are:
GlaxoSmithKline
Allergan Plc
Abbott Laboratories
Pfizer, Inc
Takeda Pharmaceutical
Novartis International AG
Lannett Company, Inc
Sanofi
AbbVie, Inc
Merck KGaA
Mylan N.V
Table of Contents
1 Thyroid Gland Disorders Treatment Market Overview
1.1 Product Overview and Scope of Thyroid Gland Disorders Treatment
1.2 Classification of Thyroid Gland Disorders Treatment by Type
1.2.1 Global Thyroid Gland Disorders Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Thyroid Gland Disorders Treatment Revenue Market Share by Type in 2019
1.2.3 Hypothyroidism
1.2.4 Hyperthyroidism
1.3 Global Thyroid Gland Disorders Treatment Market by Application
1.3.1 Overview: Global Thyroid Gland Disorders Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Thyroid Gland Disorders Treatment Market by Regions
1.4.1 Global Thyroid Gland Disorders Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Thyroid Gland Disorders Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Thyroid Gland Disorders Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Thyroid Gland Disorders Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Thyroid Gland Disorders Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Thyroid Gland Disorders Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Thyroid Gland Disorders Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GlaxoSmithKline SWOT Analysis
2.1.4 GlaxoSmithKline Product and Services
2.1.5 GlaxoSmithKline Thyroid Gland Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Allergan Plc
2.2.1 Allergan Plc Details
2.2.2 Allergan Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Allergan Plc SWOT Analysis
2.2.4 Allergan Plc Product and Services
2.2.5 Allergan Plc Thyroid Gland Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Abbott Laboratories
2.3.1 Abbott Laboratories Details
2.3.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Abbott Laboratories SWOT Analysis
2.3.4 Abbott Laboratories Product and Services
2.3.5 Abbott Laboratories Thyroid Gland Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer, Inc
2.4.1 Pfizer, Inc Details
2.4.2 Pfizer, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer, Inc SWOT Analysis
2.4.4 Pfizer, Inc Product and Services
2.4.5 Pfizer, Inc Thyroid Gland Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Takeda Pharmaceutical
2.5.1 Takeda Pharmaceutical Details
2.5.2 Takeda Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Takeda Pharmaceutical SWOT Analysis
2.5.4 Takeda Pharmaceutical Product and Services
2.5.5 Takeda Pharmaceutical Thyroid Gland Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis International AG
2.6.1 Novartis International AG Details
2.6.2 Novartis International AG Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novartis International AG SWOT Analysis
2.6.4 Novartis International AG Product and Services
2.6.5 Novartis International AG Thyroid Gland Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Lannett Company, Inc
2.7.1 Lannett Company, Inc Details
2.7.2 Lannett Company, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Lannett Company, Inc SWOT Analysis
2.7.4 Lannett Company, Inc Product and Services
2.7.5 Lannett Company, Inc Thyroid Gland Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Sanofi SWOT Analysis
2.8.4 Sanofi Product and Services
2.8.5 Sanofi Thyroid Gland Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 AbbVie, Inc
2.9.1 AbbVie, Inc Details
2.9.2 AbbVie, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 AbbVie, Inc SWOT Analysis
2.9.4 AbbVie, Inc Product and Services
2.9.5 AbbVie, Inc Thyroid Gland Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Merck KGaA
2.10.1 Merck KGaA Details
2.10.2 Merck KGaA Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Merck KGaA SWOT Analysis
2.10.4 Merck KGaA Product and Services
2.10.5 Merck KGaA Thyroid Gland Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.11 Mylan N.V
2.11.1 Mylan N.V Details
2.11.2 Mylan N.V Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Mylan N.V SWOT Analysis
2.11.4 Mylan N.V Product and Services
2.11.5 Mylan N.V Thyroid Gland Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Thyroid Gland Disorders Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Thyroid Gland Disorders Treatment Players Market Share
3.2.2 Top 10 Thyroid Gland Disorders Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Thyroid Gland Disorders Treatment Revenue and Market Share by Regions
4.2 North America Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
5 North America Thyroid Gland Disorders Treatment Revenue by Countries
5.1 North America Thyroid Gland Disorders Treatment Revenue by Countries (2015-2020)
5.2 USA Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
6 Europe Thyroid Gland Disorders Treatment Revenue by Countries
6.1 Europe Thyroid Gland Disorders Treatment Revenue by Countries (2015-2020)
6.2 Germany Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
6.4 France Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Thyroid Gland Disorders Treatment Revenue by Countries
7.1 Asia-Pacific Thyroid Gland Disorders Treatment Revenue by Countries (2015-2020)
7.2 China Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
7.5 India Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
8 South America Thyroid Gland Disorders Treatment Revenue by Countries
8.1 South America Thyroid Gland Disorders Treatment Revenue by Countries (2015-2020)
8.2 Brazil Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Thyroid Gland Disorders Treatment by Countries
9.1 Middle East & Africa Thyroid Gland Disorders Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Thyroid Gland Disorders Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Thyroid Gland Disorders Treatment Market Forecast by Type (2019-2024)
10.3 Hypothyroidism Revenue Growth Rate (2015-2025)
10.4 Hyperthyroidism Revenue Growth Rate (2015-2025)
11 Global Thyroid Gland Disorders Treatment Market Segment by Application
11.1 Global Thyroid Gland Disorders Treatment Revenue Market Share by Application (2015-2020)
11.2 Thyroid Gland Disorders Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Thyroid Gland Disorders Treatment Market Size Forecast (2021-2025)
12.1 Global Thyroid Gland Disorders Treatment Market Size Forecast (2021-2025)
12.2 Global Thyroid Gland Disorders Treatment Market Forecast by Regions (2021-2025)
12.3 North America Thyroid Gland Disorders Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Thyroid Gland Disorders Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Thyroid Gland Disorders Treatment Revenue Market Forecast (2021-2025)
12.6 South America Thyroid Gland Disorders Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Thyroid Gland Disorders Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Thyroid Gland Disorders Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Thyroid Gland Disorders Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Thyroid Gland Disorders Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Thyroid Gland Disorders Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. GlaxoSmithKline Corporate Information, Location and Competitors
Table 6. GlaxoSmithKline Thyroid Gland Disorders Treatment Major Business
Table 7. GlaxoSmithKline Thyroid Gland Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 8. GlaxoSmithKline SWOT Analysis
Table 9. GlaxoSmithKline Thyroid Gland Disorders Treatment Product and Solutions
Table 10. GlaxoSmithKline Thyroid Gland Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Allergan Plc Corporate Information, Location and Competitors
Table 12. Allergan Plc Thyroid Gland Disorders Treatment Major Business
Table 13. Allergan Plc Thyroid Gland Disorders Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Allergan Plc SWOT Analysis
Table 15. Allergan Plc Thyroid Gland Disorders Treatment Product and Solutions
Table 16. Allergan Plc Thyroid Gland Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Abbott Laboratories Corporate Information, Location and Competitors
Table 18. Abbott Laboratories Thyroid Gland Disorders Treatment Major Business
Table 19. Abbott Laboratories Thyroid Gland Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Abbott Laboratories SWOT Analysis
Table 21. Abbott Laboratories Thyroid Gland Disorders Treatment Product and Solutions
Table 22. Abbott Laboratories Thyroid Gland Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Pfizer, Inc Corporate Information, Location and Competitors
Table 24. Pfizer, Inc Thyroid Gland Disorders Treatment Major Business
Table 25. Pfizer, Inc Thyroid Gland Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Pfizer, Inc SWOT Analysis
Table 27. Pfizer, Inc Thyroid Gland Disorders Treatment Product and Solutions
Table 28. Pfizer, Inc Thyroid Gland Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Takeda Pharmaceutical Corporate Information, Location and Competitors
Table 30. Takeda Pharmaceutical Thyroid Gland Disorders Treatment Major Business
Table 31. Takeda Pharmaceutical Thyroid Gland Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Takeda Pharmaceutical SWOT Analysis
Table 33. Takeda Pharmaceutical Thyroid Gland Disorders Treatment Product and Solutions
Table 34. Takeda Pharmaceutical Thyroid Gland Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Novartis International AG Corporate Information, Location and Competitors
Table 36. Novartis International AG Thyroid Gland Disorders Treatment Major Business
Table 37. Novartis International AG Thyroid Gland Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Novartis International AG SWOT Analysis
Table 39. Novartis International AG Thyroid Gland Disorders Treatment Product and Solutions
Table 40. Novartis International AG Thyroid Gland Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Lannett Company, Inc Corporate Information, Location and Competitors
Table 42. Lannett Company, Inc Thyroid Gland Disorders Treatment Major Business
Table 43. Lannett Company, Inc Thyroid Gland Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Lannett Company, Inc SWOT Analysis
Table 45. Lannett Company, Inc Thyroid Gland Disorders Treatment Product and Solutions
Table 46. Lannett Company, Inc Thyroid Gland Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Sanofi Corporate Information, Location and Competitors
Table 48. Sanofi Thyroid Gland Disorders Treatment Major Business
Table 49. Sanofi Thyroid Gland Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 50. Sanofi SWOT Analysis
Table 51. Sanofi Thyroid Gland Disorders Treatment Product and Solutions
Table 52. Sanofi Thyroid Gland Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. AbbVie, Inc Corporate Information, Location and Competitors
Table 54. AbbVie, Inc Thyroid Gland Disorders Treatment Major Business
Table 55. AbbVie, Inc Thyroid Gland Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 56. AbbVie, Inc SWOT Analysis
Table 57. AbbVie, Inc Thyroid Gland Disorders Treatment Product and Solutions
Table 58. AbbVie, Inc Thyroid Gland Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Merck KGaA Corporate Information, Location and Competitors
Table 60. Merck KGaA Thyroid Gland Disorders Treatment Major Business
Table 61. Merck KGaA Thyroid Gland Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 62. Merck KGaA SWOT Analysis
Table 63. Merck KGaA Thyroid Gland Disorders Treatment Product and Solutions
Table 64. Merck KGaA Thyroid Gland Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Mylan N.V Corporate Information, Location and Competitors
Table 66. Mylan N.V Thyroid Gland Disorders Treatment Major Business
Table 67. Mylan N.V Thyroid Gland Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 68. Mylan N.V SWOT Analysis
Table 69. Mylan N.V Thyroid Gland Disorders Treatment Product and Solutions
Table 70. Mylan N.V Thyroid Gland Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Global Thyroid Gland Disorders Treatment Revenue (Million USD) by Players (2015-2020)
Table 72. Global Thyroid Gland Disorders Treatment Revenue Share by Players (2015-2020)
Table 73. Global Thyroid Gland Disorders Treatment Revenue (Million USD) by Regions (2015-2020)
Table 74. Global Thyroid Gland Disorders Treatment Revenue Market Share by Regions (2015-2020)
Table 75. North America Thyroid Gland Disorders Treatment Revenue by Countries (2015-2020)
Table 76. North America Thyroid Gland Disorders Treatment Revenue Market Share by Countries (2015-2020)
Table 77. Europe Thyroid Gland Disorders Treatment Revenue (Million USD) by Countries (2015-2020)
Table 78. Asia-Pacific Thyroid Gland Disorders Treatment Revenue (Million USD) by Countries (2015-2020)
Table 79. South America Thyroid Gland Disorders Treatment Revenue by Countries (2015-2020)
Table 80. South America Thyroid Gland Disorders Treatment Revenue Market Share by Countries (2015-2020)
Table 81. Middle East and Africa Thyroid Gland Disorders Treatment Revenue (Million USD) by Countries (2015-2020)
Table 82. Middle East and Africa Thyroid Gland Disorders Treatment Revenue Market Share by Countries (2015-2020)
Table 83. Global Thyroid Gland Disorders Treatment Revenue (Million USD) by Type (2015-2020)
Table 84. Global Thyroid Gland Disorders Treatment Revenue Share by Type (2015-2020)
Table 85. Global Thyroid Gland Disorders Treatment Revenue Forecast by Type (2021-2025)
Table 86. Global Thyroid Gland Disorders Treatment Revenue by Application (2015-2020)
Table 87. Global Thyroid Gland Disorders Treatment Revenue Share by Application (2015-2020)
Table 88. Global Thyroid Gland Disorders Treatment Revenue Forecast by Application (2021-2025)
Table 89. Global Thyroid Gland Disorders Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Thyroid Gland Disorders Treatment Picture
Figure 2. Global Thyroid Gland Disorders Treatment Revenue Market Share by Type in 2019
Figure 3. Hypothyroidism Picture
Figure 4. Hyperthyroidism Picture
Figure 5. Thyroid Gland Disorders Treatment Revenue Market Share by Application in 2019
Figure 6. Hospitals Picture
Figure 7. Clinics Picture
Figure 8. Other Picture
Figure 9. Global Thyroid Gland Disorders Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Thyroid Gland Disorders Treatment Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Thyroid Gland Disorders Treatment Revenue Market Share in 2019
Figure 18. Global Top 10 Players Thyroid Gland Disorders Treatment Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Thyroid Gland Disorders Treatment Revenue Market Share by Regions (2015-2020)
Figure 22. Global Thyroid Gland Disorders Treatment Revenue Market Share by Regions in 2018
Figure 23. North America Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 24. Europe Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 26. South America Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 28. North America Thyroid Gland Disorders Treatment Revenue Market Share by Countries (2015-2020)
Figure 29. North America Thyroid Gland Disorders Treatment Revenue Market Share by Countries in 2019
Figure 30. USA Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 31. Canada Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Europe Thyroid Gland Disorders Treatment Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Thyroid Gland Disorders Treatment Revenue Market Share by Countries in 2019
Figure 35. Germany Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 36. UK Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 37. France Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 38. Russia Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Italy Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Thyroid Gland Disorders Treatment Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Thyroid Gland Disorders Treatment Revenue Market Share by Countries in 2019
Figure 42. China Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Japan Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Korea Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 45. India Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 47. South America Thyroid Gland Disorders Treatment Revenue Market Share by Countries (2015-2020)
Figure 48. South America Thyroid Gland Disorders Treatment Revenue Market Share by Countries in 2019
Figure 49. Brazil Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Thyroid Gland Disorders Treatment Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Thyroid Gland Disorders Treatment Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 54. UAE Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Thyroid Gland Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 57. Global Thyroid Gland Disorders Treatment Revenue Share by Type (2015-2020)
Figure 58. Global Thyroid Gland Disorders Treatment Revenue Share by Type in 2019
Figure 59. Global Thyroid Gland Disorders Treatment Market Share Forecast by Type (2021-2025)
Figure 60. Global Hypothyroidism Revenue Growth Rate (2015-2020)
Figure 61. Global Hyperthyroidism Revenue Growth Rate (2015-2020)
Figure 62. Global Thyroid Gland Disorders Treatment Revenue Share by Application (2015-2020)
Figure 63. Global Thyroid Gland Disorders Treatment Revenue Share by Application in 2019
Figure 64. Global Thyroid Gland Disorders Treatment Market Share Forecast by Application (2021-2025)
Figure 65. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 66. Global Clinics Revenue Growth Rate (2015-2020)
Figure 67. Global Other Revenue Growth Rate (2015-2020)
Figure 68. Global Thyroid Gland Disorders Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Thyroid Gland Disorders Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Thyroid Gland Disorders Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Thyroid Gland Disorders Treatment Revenue Market Forecast (2021-2025)
Figure 72. Europe Thyroid Gland Disorders Treatment Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Thyroid Gland Disorders Treatment Revenue Market Forecast (2021-2025)
Figure 74. South America Thyroid Gland Disorders Treatment Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Thyroid Gland Disorders Treatment Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
甲状腺ホルモン障害薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Thyroid Hormone Disorder Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Thyroid Hormone…- 難燃ケーブルグランドの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Flameproof Cable Gland market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Flameproof Cable Gland…
- 甲状腺機能検査の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Thyroid Function Test market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.2% in the forecast period of 2020 to 2025 and will expected to reach USD 1333.8 million by 2025, from USD 1175.8 million in 2019. The Thyroid Functi…
- 甲状腺がん検査の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Thyroid Cancer Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Thyroid Cancer Testing…
- 骨髄増殖性疾患薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Myeloproliferative Disorders Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.8% in the forecast period of 2020 to 2025 and will expected to reach USD 7146 million by 2025, from USD 6642.1 million in 2019. The Mye…